Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Jan 31, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Apellis Pharmaceuticals, Inc.
-1.25K
$65.12
-$81,401.71
-2.62%
46.39K
Jan 29 - Jan 30
Scheduled
Apellis Pharmaceuticals, Inc.
-4.29K
$63.69
-$272,975.34
-8.25%
47.64K
Jan 23
Scheduled
Apellis Pharmaceuticals, Inc.
-1.74K
$65.00
-$112,963.05
-3.24%
51.92K
Jan 22
Apellis Pharmaceuticals, Inc.
-3.28K
$65.58
-$214,840.08
-5.75%
53.66K
Jan 17
Scheduled
Apellis Pharmaceuticals, Inc.
15.33K
$66.81
-$109,031.64
+36.85%
56.94K
Jan 16
Apellis Pharmaceuticals, Inc.
0
$60.06
-$259,450.00
—
41.5K
Jun 1
Apellis Pharmaceuticals, Inc.
0
$54.56
-$204,450.00
—
41.43K
Apr 3
Apellis Pharmaceuticals, Inc.
-1.10K
$68.76
-$75,911.04
-2.60%
41.43K
Feb 23
Scheduled
Apellis Pharmaceuticals, Inc.
6.08K
$58.50
-$32,350.50
+16.66%
42.53K
Feb 21
Apellis Pharmaceuticals, Inc.
-883.00
$52.76
-$46,587.08
-2.36%
36.46K
Jan 30
Scheduled
Apellis Pharmaceuticals, Inc.
-367.00
$52.77
-$19,366.59
-0.97%
37.34K
Jan 27
Apellis Pharmaceuticals, Inc.
-2.96K
$51.58
-$152,418.90
-7.27%
37.71K
Jan 23
Scheduled
Apellis Pharmaceuticals, Inc.
-1.41K
$52.05
-$73,442.55
-3.35%
40.66K
Jan 20
Apellis Pharmaceuticals, Inc.
18.38K
—
—
+40.04%
64.3K
Apr 25 - Jan 12
Apellis Pharmaceuticals, Inc.
-434.00
$38.59
-$16,748.06
-1.82%
23.47K
Jan 28
Apellis Pharmaceuticals, Inc.
17.47K
—
—
+271.13%
23.91K
Jan 21
Apellis Pharmaceuticals, Inc.
6.25K
—
—
∞
6.25K
Jan 28
Apellis Pharmaceuticals, Inc.
0
—
—
—
0

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...